Prioritise and prevent Hepatitis – A growing concern – ETHealthWorld

Share Article

We have updated our terms and conditions and privacy policy
Click “Continue” to accept and continue with ET HealthWorld
Dear user,

ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Please review and accept these changes below to continue using the website.

You can see our privacy policy & our cookie policy. We use cookies to ensure the best experience for you on our website.

If you choose to ignore this message, we’ll assume that you are happy to receive all cookies on ET HealthWorld.
HealthTrip expects to clock $20 million revenues in FY23 on the back of government’s Heal in India initiative
Monkeypox can heal itself but will cause more deaths: WHO
16 September, 2022


25 February, 2022
25 February, 2022
25 November, 2022
1 Octuber, 2021

Rebooting Cancer Awareness
The unsung hero in faster holistic recovery
Technological Disruption in Indian Health & Pharma
Do you think you are up for the challenge?
Holistic Solutions For A Healthier India





17 July

Adopting-Dynamic-Technologies



As of 21 April 2022, at least 169 cases of acute hepatitis of unknown origin have been reported from 11 countries in the WHO European Region and one country in the WHO Region of the Americas. Adenovirus has been detected in at least 74 cases, and of the number of cases with information on molecular testing, 18 have been identified as F type 41. SARS-CoV-2 was identified in 20 cases of those that were tested. Furthermore, 19 were detected with a SARS-CoV-2 and adenovirus co-infection.
Get exclusive Industry Insights and Analysis through our “Exclusive” Stories brought to you by our award-winning journalists
By continuing, you agree to the Terms & Conditions and acknowledge our Privacy Policy. This same account can be used across all Economic Times B2B portals.
Recommended by ColombiaColumbia
125000+ Industry Leaders read it everyday
Representatives of several small and medium pharma companies have suggested that the government adopt a “one molecule-one MRP” formula instead of trade margin rationalisation (TMR) on non-scheduled drugs to reduce their prices.
Pharmacists in Gujarat have geared up to give a tough fight to online medicine retailers by enabling people to get medicines at their doorsteps at competitive prices.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc.
Please contact us to know more details.
Get ETHealthworld‘s top stories every morning in your email inbox.
125000+ Industry Leaders read it everyday
Follow @ETHealthworld for the latest news, insider access to events and more.

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness